Timothy Squire is one of Canada's leading life sciences industry practitioners. With his extensive regulatory and commercialization experience, Tim has become a trusted advisor to stakeholders in the drug, medical device, natural health product, cosmetic and food industries in Canada and from around the world.
Tim’s practice is devoted to the Life Sciences industry, and he is the former Chair of the firm's International Life Sciences Industry Group. He adds substantial bench strength given his extensive knowledge and experience across the entire health product lifecycle. Tim has become a trusted advisor to many stakeholders in the drug, medical device, natural health product, cosmetic and food industries in Canada and around the world due to his in-depth knowledge and commitment to client service.
Tim's regulatory practice covers all aspects of health product regulation and market access, and he is one of the few practitioners in Canada regularly called upon to help solve complex health product compliance and enforcement issues. To this end, Tim frequently communicates with Health Canada and other federal and provincial regulators on our clients’ behalf.
In addition to his regulatory acumen, Tim also negotiates and drafts sophisticated commercial arrangements for Life Sciences clients, including license agreements, distribution agreements, manufacturing and supply agreements, quality and pharmacovigilance agreements, technology and material transfer agreements, joint R&D agreements, and funding agreements.
Tim also quarterbacks regulatory due diligence in complex domestic and cross-border transactions involving drug, medical device, natural health product, cosmetic, and food companies, and is often called upon to manage post-closing integration, including the transition of market authorizations and regulatory operations.
Tim performs in-house legal functions for several U.S. and international clients without Canadian in-house legal or regulatory capabilities, and in this capacity has developed a comprehensive understanding of the business issues and pressures facing companies in the life sciences industry.
Tim’s authority in the life sciences sector has been recognized by Chambers Canada, Who’s Who Legal, Lexpert, IAM Strategy 300: The World’s Leading IP Strategists, and he has received LMG’s Life Sciences Canadian Regulatory Attorney of the Year award three times, most recently in 2020.
